Zanubrutinib CLL trial NCT07899398 explained
Trial watch on NCT07899398, a phase 2 zanubrutinib study in CLL, with ChEMBL potency and ClinicalTrials.gov counts for the drug as of 2026-11-13.
Blog
Worked examples from BioQ: genes, drugs, trials, structures and papers searched across 97 bio databases — with the real results, the sources and the exact query to repeat.
Trial watch on NCT07899398, a phase 2 zanubrutinib study in CLL, with ChEMBL potency and ClinicalTrials.gov counts for the drug as of 2026-11-13.
A new DYRK1A study in pancreatic cancer, set against DepMap dependency, ChEMBL compounds, Open Targets diseases and TCGA expression as of 2026-11-13.
NCT07905456 is a PHASE2 gingivitis trial starting 2026-12-01; we checked chlorhexidine in ChEMBL (104 targets) and ClinicalTrials.gov (101 studies).
BTK vs ITK compared in DepMap Chronos data and drug annotations: BTK is a dependency in 5 of 1178 cell lines, ITK in none; 30 drugs versus 4 listed.
A 2026 eLife paper on a TNKS PROTAC in colorectal cancer, placed in context with DepMap, ChEMBL, Open Targets, Reactome and STRING data as of 2026-11-12.
NCT06966843 tests dantrolene in statin-induced myopathy; BioQ pulls its ChEMBL potency and 7 registered dantrolene trials, data as of 2026-11-11.
A 2026 JCI Insight paper links CALR mutations to HLA class I expression in MPN; BioQ data show CALR dependency, disease links and partners across 7 resources.
NCT07916844 tests hepatic arterial infusion chemotherapy versus capecitabine in resected biliary tract cancer; ChEMBL and 1231 oxaliplatin studies.
A new npj Dementia paper on MAPT V337M organoids, placed in context with DepMap, Open Targets, ChEMBL, STRING and Reactome data as of 2026-11-10.
WEE1 is a DepMap common-essential gene (1178 of 1178 cell lines dependent); one BioQ query adds drugs, disease evidence, expression and pathways.
How to read the cancer lineage dependency of a gene in one query: KRAS across 1178 DepMap Chronos cell lines, with 91.5% of pancreas lines dependent.
ROS1 dependency and drugs from one query: 0 of 1178 DepMap lines dependent, 5 drugs in ChEMBL and Open Targets, 711 disease links, as of 2026-11-06.